CCT3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.249200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.953000E-01
Normal-vs-Stage2
2.289200E-01
Normal-vs-Stage3
7.086800E-01
Normal-vs-Stage4
1.023370E-01
Stage1-vs-Stage2
7.509000E-01
Stage1-vs-Stage3
5.321800E-01
Stage1-vs-Stage4
6.599400E-01
Stage2-vs-Stage3
4.240400E-01
Stage2-vs-Stage4
3.556800E-01
Stage3-vs-Stage4
3.402400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.468600E-01
Normal-vs-AfricanAmerican
8.712400E-02
Normal-vs-Asian
1.523410E-01
Caucasian-vs-AfricanAmerican
5.393400E-01
Caucasian-vs-Asian
2.381800E-01
AfricanAmerican-vs-Asian
8.248800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.935650E-01
Normal-vs-Female
2.707000E-01
Male-vs-Female
2.406000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.200600E-01
Normal-vs-Age(41-60Yrs)
1.533160E-01
Normal-vs-Age(61-80Yrs)
2.901800E-01
Normal-vs-Age(81-100Yrs)
1.136030E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.902600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.980400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.723400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.123400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.868600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.671380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.411600E-01
Normal-vs-Daily Drinker
5.213800E-01
Normal-vs-Weekly Drinker
1.130080E-02
Normal-vs-Occasional Drinker
1.303700E-02
Normal-vs-Social Drinker
2.535600E-01
Non Drinker-vs-Daily Drinker
6.718200E-01
Non Drinker-vs-Weekly Drinker
1.503350E-01
Non Drinker-vs-Occasional Drinker
1.438130E-02
Non Drinker-vs-Social Drinker
9.732200E-01
Daily Drinker-vs-Weekly Drinker
8.154100E-02
Daily Drinker-vs-Occasional Drinker
3.635200E-03
Daily Drinker-vs-Social Drinker
6.961000E-01
Weekly Drinker-vs-Occasional Drinker
5.892400E-01
Weekly Drinker-vs-Social Drinker
1.630040E-01
Occasional Drinker-vs-Social Drinker
5.958200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.518800E-01
Normal-vs-Grade 2
9.070800E-01
Normal-vs-Grade 3
8.651600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.344800E-01
Grade 1-vs-Grade 3
2.483200E-01
Grade 1-vs-Grade 4
9.518800E-01
Grade 2-vs-Grade 3
3.656800E-01
Grade 2-vs-Grade 4
9.070800E-01
Grade 3-vs-Grade 4
8.651600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.072000E-01
Normal-vs-NonDiabetic
1.767800E-01
Diabetic-vs-NonDiabetic
2.215200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.161600E-02
Normal-vs-NoPancreatitis
2.376600E-01
Pancreatitis-vs-NoPancreatitis
9.775600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.256590E-01
Normal-vs-N1
2.733800E-01
N0-vs-N1
7.255600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.95159999961359E-07
Normal-vs-TP53-NonMutant
2.160100E-03
TP53-Mutant-vs-TP53-NonMutant
2.258000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
